Regulatory News
Tuesday, January 17, 2017
UPDATE 1-FDA approves generic version of Jazz Pharma's sleep disorder drug
Jan 17 (Reuters) - The U.S. Food and Drug Administration
said it had approved the first generic version of Xyrem, Jazz
Pharmaceuticals Plc's drug to treat patients with
narcolepsy, a kind of sleeping...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment